Douglas J. Hughes - 10 Jan 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Douglas J. Hughes
Issuer symbol
IMVT
Transactions as of
10 Jan 2022
Transactions value $
$0
Form type
4
Filing time
12 Jan 2022, 16:00:26 UTC
Previous filing
30 Aug 2021
Next filing
19 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +21.7K +37.17% $0.00 80.2K 10 Jan 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +71.5K +52% $0.00 209K 10 Jan 2022 Common Stock 71.5K $7.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F3 Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney